Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism

2013 ◽  
Vol 64 (4) ◽  
pp. 484-493 ◽  
Author(s):  
Toyonori Tsuzuki ◽  
Naoto Sassa ◽  
Yoshie Shimoyama ◽  
Takamitsu Morikawa ◽  
Ryoichi Shiroki ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma

scholarly journals Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma

2014 ◽  
Vol 55 (2) ◽  
pp. 242-247 ◽  
Author(s):  
C. H. J. Muselaers ◽  
A. B. Stillebroer ◽  
I. M. E. Desar ◽  
M. J. Boers-Sonderen ◽  
C. M. L. van Herpen ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma

scholarly journals MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients

Oncotarget ◽  
2016 ◽  
Vol 7 (48) ◽  
pp. 78433-78447 ◽  
Author(s):  
Magdalena Lukamowicz-Rajska ◽  
Christiane Mittmann ◽  
Michael Prummer ◽  
Qing Zhong ◽  
Jens Bedke ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma ◽  
Inhibitor Treatment
Sign in / Sign up

Export Citation Format

Share Document